AMGN
Amgen Inc
Biotechnology
Amgen Inc (AMGN) Financials
Annual revenue, profit, EPS and free cash flow for AMGN, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $36.8B | — | $9.1B | — | $14.23 | $8.1B |
| FY2024 | $33.4B | — | $7.3B | — | $7.56 | $10.4B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.